Pembrolizumab combined with stereotactic body radiotherapy in a patient with human immunodeficiency virus and advanced non-small cell lung cancer: a case report

Pembrolizumab combined with stereotactic body radiotherapy in a patient with human immunodeficiency virus and advanced non-small cell lung cancer: a case report

Abstract Background Pembrolizumab has significantly improved outcomes in patients with advanced non-small cell lung cancer. Combining programmed death-1 inhibitor with stereotactic body radiotherapy showed a slight toxicity and good benefits in recent clinical trials. However, patients infected with...

Full description

Bibliographic Details
Main Authors: Dongqi Li, Chuanchun He, Yaoxiong Xia, Yaxi Du, Jing Zhang
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Journal of Medical Case Reports
Subjects:
Pembrolizumab
Stereotactic body radiotherapy
Immune-related adverse events
Non-small cell lung cancer
HIV
Online Access:http://link.springer.com/article/10.1186/s13256-018-1667-2

Internet

http://link.springer.com/article/10.1186/s13256-018-1667-2

Similar Items